Top Markets
Coin of the day
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Ранг среди акций #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Цена акции
$8.46
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$514.33M
Изменение (1 день)
-2.08%
Изменение (1 год)
128.03%
Страна
US
Торговля Kyverna Therapeutics, Inc. (KYTX)

Категория

История дроблений акций Kyverna Therapeutics, Inc. (KYTX)
Акции Kyverna Therapeutics, Inc. (символ: KYTX) прошли через 0 дроблений.
Последнее дробление произошло Aug 31, 2026.
Одна акция KYTX, купленная до Aug 31, 2026, сейчас соответствует 0 акциям KYTX.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH